Unibest
← Back to patent-cliff list

CAS 109-65-9

1-Bromobutanen-Butyl bromide

Codes: Tetracaine-009, (VI)91311-1-a, (VI)91311-2-a

Application context (from source-drug indications)

AnaesthesiaOxymetazoline Hydrochloride/Tetracaine HydrochloridePeriapical periodontitisOxymetazoline Hydrochloride/Tetracaine HydrochlorideDental cariesOxymetazoline Hydrochloride/Tetracaine HydrochloridePainBupivacaine Hydrochloride/Fentanyl CitrateAnaesthesiaTetracaine HydrochlorideRetinitis pigmentosaTetracaine HydrochloridePainTetracaine HydrochlorideSubacromial impingement syndromeBupivacainePostoperative painBupivacaineStomatitisBupivacaineHead and neck cancerBupivacaineHypotensionBupivacaineMitral regurgitationBupivacaine

Source drugs (routes using this intermediate)

DrugTierExpiry
Oxymetazoline Hydrochloride/Tetracaine HydrochlorideTier C — Watch / trade-
Bupivacaine Hydrochloride/Fentanyl CitrateTier C — Watch / trade-
Tetracaine HydrochlorideTier C — Watch / trade-
BupivacaineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Bupivacaine Hydrochloride/Fentanyl CitrateOptimised routesteps: 3total yield: /
BupivacaineOptimised routesteps: 3total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.